stockrow
Friday 6 November 2026
Export CHE’s income statement to Excel — free account
Chemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +23.1%
- Free cash flow
- −45.3%
Quarter to September 2026, against a year earlier
528.00
5.77
−1.08%
Follow CHE
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
23.19 | 26.33 | 32.31 | 30.32 | 30.83 | 26.59 | 31.92 | 22.13 | 40.42 | 24.38 |
Piotroski F-Score |
6 | 7 | 5 | 6 | 6 | 8 | 6 | 7 | 7 | 6 |
P/S ratio |
2.43 | 3.27 | 3.89 | 3.54 | 3.88 | 4.09 | 3.62 | 2.55 | 2.38 | 1.68 |
Altman Z-Score |
11.69 | 13.23 | 13.65 | 11.49 | 11.34 | 13.61 | 11.47 | 11.48 | 9.94 | 8.41 |
Altman Z″-Score (non-manufacturers) |
9.65 | 9.36 | 8.97 | 7.76 | 7.06 | 7.65 | 6.07 | 7.18 | 5.88 | 6.45 |
P/FCF ratio |
18.67 | 21.44 | 32.10 | 29.69 | 33.05 | 19.66 | 28.26 | 19.42 | 40.39 | 27.77 |
Beneish M-Score |
(2.76) | (2.78) | (2.33) | (2.58) | (2.67) | (3.22) | (2.59) | (2.77) | (2.96) | (2.42) |
P/Operating CF |
46.13 | 48.27 | 81.04 | 75.53 | 130.42 | 97.81 | 110.28 | 80.47 | (139.18) | 377.25 |
Dividend Safety Score |
100 | — | — | — | — | — | — | — | — | — |
P/B ratio |
6.29 | 7.11 | 7.94 | 9.47 | 13.30 | 9.43 | 9.65 | 7.69 | 7.34 | 5.07 |
Price to Tangible BV |
26.83 | 22.11 | 20.34 | 64.30 | 0.00 | 41.55 | 306.70 | 363.62 | 461.03 | 0.00 |
EV/Sales |
2.45 | 3.24 | 3.81 | 3.56 | 3.97 | 4.07 | 3.69 | 2.60 | 2.43 | 1.74 |
EV/EBITDA |
15.34 | 18.34 | 21.49 | 18.84 | 21.11 | 18.97 | 23.60 | 16.39 | 26.97 | 12.74 |
EV/Operating CF |
15.94 | 18.89 | 26.15 | 24.50 | 27.52 | 17.31 | 23.73 | 16.17 | 24.96 | 20.31 |
EV/FCF |
18.75 | 21.24 | 31.52 | 29.78 | 33.86 | 19.60 | 28.79 | 19.82 | 41.30 | 28.75 |
Quick Ratio |
0.90 | 1.22 | 1.43 | 0.72 | 0.56 | 0.97 | 0.57 | 0.65 | 0.64 | 0.86 |
Current Ratio |
1.05 | 1.38 | 1.61 | 0.92 | 0.76 | 1.10 | 0.73 | 0.83 | 0.91 | 0.99 |
Net Debt/EBITDA |
(0.18) | (0.41) | (0.66) | 0.06 | 0.50 | (0.06) | 0.44 | 0.35 | 0.60 | 0.43 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 6.76% | 17.50% | 9.41% | 10.96% | 10.58% | 11.00% | 12.36% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.12 | 0.38 | 0.15 | 0.19 | 0.17 | 0.19 | 0.21 |
Asset Turnover |
1.58 | 1.46 | 1.46 | 1.53 | 1.54 | 1.54 | 1.73 | 1.88 | 1.85 | 1.82 |
Operating CF/Net income |
1.46 | 1.38 | 1.21 | 1.24 | 1.15 | 1.53 | 1.37 | 1.40 | 1.66 | 1.25 |
Capex/Depreciation |
(0.89) | (0.73) | (0.91) | (0.92) | (0.97) | (1.00) | (1.16) | (1.33) | (1.72) | (1.07) |
Interest Coverage |
193.28 | 205.90 | 109.58 | 74.93 | 183.64 | 165.47 | 56.75 | 48.82 | 26.46 | 48.12 |
| 25.28% | 27.12% | 28.59% | 35.11% | 35.23% | 39.25% | 33.37% | 36.33% | 18.45% | 20.97% | |
| 16.54% | 18.10% | 17.52% | 17.93% | 19.34% | 23.64% | 19.60% | 21.69% | 10.91% | 12.55% | |
ROIC |
23.36% | 24.35% | 25.22% | 26.11% | 25.98% | 27.88% | 18.72% | 22.08% | 11.21% | 18.09% |
Return on Tangible Assets |
119.94% | 97.45% | 69.41% | 142.54% | 220.91% | 146.47% | 211.03% | 157.86% | 78.19% | 91.10% |
Average Days of Receivables |
26.34 | 25.70 | 29.26 | 23.83 | 23.41 | 22.26 | 27.08 | 24.47 | 24.89 | 30.56 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
16.49% | 17.45% | 17.45% | 16.80% | 17.14% | 15.88% | 15.77% | 15.21% | 16.60% | 15.45% |
Intangible Assets out of Total Assets |
0.49 | 0.45 | 0.40 | 0.47 | 0.51 | 0.49 | 0.55 | 0.59 | 0.58 | 0.60 |
Share Based Compensation of Revenue |
1.48% | 2.09% | 1.74% | 1.52% | 1.41% | 1.23% | 1.06% | 1.01% | 0.86% | 0.61% |
Graham Net Nets |
(0.04) | (0.02) | (0.01) | (0.05) | (0.06) | (0.02) | (0.05) | (0.05) | (0.05) | (0.07) |
Graham Number |
168.04 | 183.62 | 173.10 | 141.87 | 123.92 | 159.55 | 118.69 | 102.98 | 68.02 | 69.19 |
Earnings Yield |
4.31% | 3.80% | 3.09% | 3.30% | 3.24% | 3.76% | 3.13% | 4.52% | 2.47% | 4.10% |
Free Cash Flow Yield |
5.36% | 4.66% | 3.12% | 3.37% | 3.03% | 5.09% | 3.54% | 5.15% | 2.48% | 3.60% |
Revenue per Share |
175.72 | 161.83 | 150.46 | 143.01 | 136.51 | 130.34 | 121.39 | 111.01 | 103.80 | 96.25 |
Operating CF per Share |
26.97 | 27.79 | 21.95 | 20.76 | 19.69 | 30.67 | 18.86 | 17.88 | 10.12 | 8.26 |
Capex per Share |
(4.04) | (3.08) | (3.74) | (3.68) | (3.69) | (3.58) | (3.32) | (3.29) | (4.00) | (2.43) |
Free Cash Flow per Share |
22.92 | 24.71 | 18.21 | 17.07 | 16.01 | 27.09 | 15.54 | 14.59 | 6.12 | 5.84 |
Cash per Share |
5.18 | 11.87 | 17.54 | 4.97 | 2.10 | 10.20 | 0.39 | 0.30 | 0.69 | 0.93 |
Shareholders Equity per Share |
68.02 | 74.48 | 73.61 | 53.50 | 39.77 | 56.48 | 45.50 | 36.82 | 33.65 | 31.99 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
68.02 | 74.48 | 73.61 | 53.50 | 39.77 | 56.48 | 45.50 | 36.82 | 33.65 | 31.99 |
Free Cash Flow |
330.05 | 371.28 | 274.09 | 254.89 | 250.83 | 432.15 | 248.23 | 234.27 | 98.20 | 95.62 |
Working Capital |
15.49 | 109.05 | 188.79 | (24.59) | (72.11) | 30.30 | (71.55) | (31.83) | (17.48) | (1.93) |
Capital Expenditures |
(58.23) | (46.22) | (56.21) | (54.99) | (57.77) | (57.14) | (53.02) | (52.87) | (64.30) | (39.77) |
Net Current Asset Value |
(256.17) | (154.83) | (59.38) | (370.68) | (489.16) | (204.31) | (351.04) | (224.35) | (203.63) | (186.06) |
EV/EBIT |
18.30 | 21.52 | 25.36 | 22.10 | 24.76 | 21.74 | 27.77 | 19.06 | 35.88 | 15.38 |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 |
Price to Operating Income |
18.21 | 21.72 | 25.83 | 22.03 | 24.17 | 21.81 | 27.25 | 18.67 | 35.08 | 14.86 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.32 | 0.32 | 0.30 | 0.30 | 0.31 | 0.30 | 0.26 | 0.25 | 0.26 | 0.31 |
Cash ROIC |
31.32% | 28.62% | 19.98% | 26.27% | 28.15% | 36.05% | 28.47% | 33.50% | 15.05% | 14.75% |
Accounts Receivable Turnover |
14.30 | 13.79 | 14.11 | 15.44 | 16.20 | 15.37 | 14.72 | 15.29 | 13.57 | 13.24 |
Accounts Payable Turnover |
31.43 | 29.15 | 27.67 | 23.84 | 21.52 | 26.17 | 26.10 | 24.92 | 26.16 | 26.79 |
Inventory Turnover |
216.93 | 156.16 | 131.59 | 134.43 | 159.20 | 189.35 | 200.67 | 222.42 | 207.51 | 184.84 |
Average Days of Payables |
13.78 | 10.22 | 15.95 | 11.16 | 19.46 | 14.36 | 14.12 | 14.91 | 15.35 | 12.95 |
Days of Inventory on Hand |
1.61 | 1.90 | 2.99 | 2.74 | 2.69 | 1.88 | 2.06 | 1.70 | 1.69 | 1.88 |
Average Receivables |
176.87 | 176.34 | 160.46 | 138.31 | 132.04 | 135.34 | 131.67 | 116.58 | 122.84 | 119.14 |
Average Payables |
54.30 | 54.09 | 52.96 | 57.45 | 63.63 | 52.67 | 50.63 | 49.26 | 43.98 | 41.64 |
Average Inventory |
7.87 | 10.10 | 11.14 | 10.19 | 8.60 | 7.28 | 6.58 | 5.52 | 5.54 | 6.03 |
Average Assets |
1,603.38 | 1,668.34 | 1,555.05 | 1,392.37 | 1,388.82 | 1,351.61 | 1,121.92 | 947.78 | 900.04 | 866.19 |
Average Common Equity |
1,049.20 | 1,113.43 | 953.30 | 710.99 | 762.24 | 813.90 | 658.97 | 565.84 | 532.23 | 518.68 |
Columns are period end dates · fundamentals updated 5 Nov 2026